Endothelial Dysfunction, Monocyte Activation, and Vasculopathy in Patients With Obstructive Sleep Apnea (OSA) and Effect of 6-month CPAP Treatment

NCT01312168 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Sleep Apnea, Obstructive
Continuous Positive Airway Pressure
Endothelium
Inflammation
Vascular Function

Interventions

DEVICE: Therapeutic CPAP
DEVICE: Subtherapeutic CPAP

Sponsor

National Taiwan University Hospital

Collaborators

[object Object]